Progress of maintenance therapy for advanced non-small-cell lung cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 148-151, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-489680
ABSTRACT
The efficacy of the standard first-line chemotherapy regimen for advanced non-small cell lung cancer (NSCLC) has reached a plateau.Study confirmed that chemotherapy drugs and molecular targeted drug maintenance treatment can prolong the survival of patients with advanced NSCLC.Immunotherapy has become a maintenance treatment for advanced NSCLC,and further research is needed to confirm its efficacy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS